Congress insights reporting: a best practice Q&A
Medical congresses form an essential part of pharma teams’ medical and commercial strategies. Getting them right – from planning and attendance through to the various post-congress activities – can help teams answer fundamental questions about their therapies, customers, markets, and competitors. Congress insights reporting helps pharma teams generate a higher volume of accurate, high-quality insights […]
Insights to Action: How Top Pharma Orgs Use Insights to Drive Strategy and Measure Impact
Learn how some of the most innovative pharma companies use strategic insights to gain a decisive advantage in competitive markets.
Exploring the Within3 Insights Management Platform
A Look Under the Hood of Generative AI-Powered Insights
Breaking Data Silos: Unlocking AI-Driven Insights for Pharma
Transforming pharmaceutical strategies with AI-driven insights and unified data
Scaling the mountain: medical affairs & insights implementation
How high have you climbed? We’ve identified four stages on the mountain of insights implementation – the higher you climb, the more value you’re extracting from your medical affairs insights.
Challenging the Insights Illusion
Moving Beyond Dashboards and Data Overload in Medical and Commercial Strategy
Within3 in Pharmaphorum: epiphanies in an insights-starved industry
What does pharma need to make better decisions amid vast amounts of data?
Within3 and Reuters announce state of medical affairs insights management survey results
65% say lack of insights endanger product launches, and 91% of medical affairs teams fail to use most of the data they collect to generate insights.
Insights on insights: industry survey highlights
Medical affairs leaders speak out on the challenges and opportunities of better insights management.
Oncology outlook: top challenges, tech solutions
What are oncology teams’ top challenges, and how can technology address them?
